Severe Eczema Drug Is Approved by F.D.A.; Price Tag Is $37,000 a Year quoting : The New York Times

Advertisement Continue reading the main storyDebbie Byrnes, a sixth-grade teacher from San Antonio who participated in the clinical trial, had suffered for years with severe eczema that often covered her face. But in January, the agency said that drug companies were allowed to discuss price and other issues with insurers in advance. They also often must demonstrate that other, cheaper drugs did not work before an insurer will cover more expensive drugs. He said a similar drug, nemolizumab, is also being tested for people with moderate to severe eczema and could hit the market in a few years. That is because the net price of Dupixent, Dr. Schleifer said, will still be over $30,000.



Severe Eczema Drug Is Approved by F.D.A.; Price Tag Is $37,000 a Year
The FDA approved a new addiction to treat eczema aniaostudio / Getty ImagesIt's approved for people with atopic dermatitis, a catchall term for itchy skin caused by allergy. The Food and Drug Administration approved a new drug on Tuesday to treat serious cases of eczema. In atopic dermatitis, the skin develops red, scaly and crusted bumps, which are extremely itchy," the FDA says. In a nod to the sensitivity around drug prices, the company stressed that there is no single price for the drug. "By binding to this protein, Dupixent is able to inhibit the inflammatory response that plays a role in the development of atopic dermatitis," the FDA said in a statement.

FDA Approves New Eczema Drug Dupixent

The U.S. Food and addiction Administration today approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for patients whose eczema is not controlled adequately by topical therapies, or those for whom topical therapies are not advisable. Atopic dermatitis is the most common of the many types of eczema; onset typically begins in childhood and can last through adulthood. By binding to this protein, Dupixent is able to inhibit the inflammatory response that plays a role in the development of atopic dermatitis. The cause of atopic dermatitis is a combination of genetic, immune and environmental factors.


collected by :Lucy William

To follow all the new news about From Addiction to Recovery

Comments

Popular posts from this blog

Cannabis addiction and its side effects

DMT Facts and side effects

Fresh drug abuse curing Center can Be Coming To Westchester